Diane Walker

Diane Walker is the reference editor of Peptide America, where she maintains the molecule index and writes the monographs that sit beneath it. Her working question on any compound is narrower than the one most coverage asks: not whether a peptide is promising, but what an American reader can legally obtain and what the published record actually establishes about it. She spent several years on drug development programs where the recurring problem was endpoint adjudication — whether a trial's stated measure captured the thing the trial claimed to have shown — and that habit shapes how the evidence sections here are written, which is why a monograph will often say that a finding rests on two open-label studies rather than describing it as supported.

She is not a licensed clinician; nothing on this site is medical advice, and every claim is attributed to FDA labeling, a named regulatory record, or PubMed-indexed literature cited by identifier. Where a molecule's status is unsettled the monograph says so and gives the date the status was checked. Peptide America is funded by commissions earned when readers begin care through some of the supplier links; the regulatory status of a molecule is a matter of record and is not influenced by whether anyone pays to appear beside it.